Voltar
Artigo Revisado por pares
BIBTEX RIS

Anlotinib plus etoposide and cisplatin/carboplatin as first-line therapy for extensive-stage small cell lung cancer (ES-SCLC): a single-arm, phase II study

2022; Springer Science+Business Media; Volume: 40; Issue: 5 Linguagem: Inglês

10.1007/s10637-022-01279-7

ISSN

1573-0646

Autores

Tiandong Kong, Lu Chen, Xiaoli Zhao, Fangfang Duan, Hanli Zhou, Lei Wang, Danna Liu,

Tópico(s)

Neutropenia and Cancer Infections

Referência(s)